Global Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Regional Outlook and Forecast, 2023 - 2029

The Global Leukemia Therapeutics Market size is expected to reach $11.7 billion by 2029, rising at a market growth of 6.0% CAGR during the forecast period.

Chronic lymphocytic leukemia (CLL) is the major contributor to the market because of the growing older population. Thus, it is expected to generate approximately $4,834.8 million revenue of the total market by 2029. One in six deaths, or 9.6 million, was attributed to cancer in 2018, making it the second largest cause of death worldwide. For example, in the US, CLL accounts for 25 to 30% of all cases of leukemia. The American Cancer Society predicted that in the year 2020, there would be roughly 21,040 new cases of CLL and about 4,060 fatalities. CLL/SLL is responsible for 191,000 cases and 61,000 deaths annually. Adults as young as 30 years old can develop CLL. However, people over the age of 70 are most likely to experience it. Children with CLL are incredibly uncommon. It is well known that the incidence rises quickly with age.

The major strategies followed by the market participants are partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In October, 2022, Gilead joined hands with MacroGenics to develop and commercialization of advanced monoclonal antibody-based therapeutics for the treatment of cancer. Under this collaboration, both companies would develop MGD024, an investigational, bispecific antibody that binds CD3 and CD123 utilizing MacroGenics’ DART® platform. Additionally, In October, 2022, Bristol Myers Squibb signed an agreement with Century Therapeutics and aims to develop and supply up to 4 induced pluripotent stems cell-derived, engineered natural killer cell and T cell programs for hematologic malignancies and solid tumors.

KBV Cardinal Matrix - Market Competition Analysis

Based on the Analysis presented in the Cardinal matrix; Pfizer, Inc. is the forerunner in the Leukemia Therapeutics Market. In June, 2020, Pfizer, Inc. received approval from DAURISMO, a Hedgehog pathway inhibitor, combined with low-dose cytarabine, a chemotherapy type, for the treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients. Through this approval, Pfizer would serve people living with cancers by providing a new treatment option for certain patients across Europe. Companies such as AbbVie, Inc., Bristol Myers Squibb Company, Sanofi S.A. and Gilead Sciences, Inc. are some of the key innovators in Leukemia Therapeutics Market.

Market Growth Factors

Innovative therapies for leukemia treatments

Numerous research projects are being carried out to create distinct therapeutic techniques that combine diverse medicines to boost patient outcomes for various leukemia types. For example, although chemotherapy is the standard of care, a new strategy is being used that combines chemotherapy with the medicines cytarabine and anthracyclines to enhance patient outcomes. Because many people resist several chemotherapy medications, businesses are creating immune treatments to treat this illness. Therefore, market growth is anticipated to be boosted by the development of such cutting-edge diagnostics and therapies for leukemia patients during the anticipated period.

Developing bioinformatics tool to support drug development

Pharmaceutical companies are currently concentrating their efforts on finding novel therapeutic agents and prospective new compounds that can alter the activity of the determined target. Additionally, preclinical, and clinical studies are a drawn-out, frequently pricey, and risky procedure. To boost the drug development process, an efficient and cutting-edge method of predicting drug efficacy is therefore required. Target identification, lead optimization, and lead validation can all be accomplished with the use of bioinformatic technologies like statistical algorithms. These tools support both drug development and drug discovery. The market is anticipated to expand as a result of the increasing use of a bioinformatics tool for improving current drug development solutions.

Market Restraining Factors

Side Effects of leukemia therapeutics and strict regulations

The expansion of the market for leukemia therapeutics is projected to be constrained by the side effects and unfavorable responses associated with the treatments. Chemotherapy, for example, causes side effects, including skin conditions, hair loss, infections, high blood pressure, fatigue, and other similar side effects. Different therapies also have different adverse reactions. For example, similar side events, like nausea, liver issues, hair color loss, diarrhea, and vomiting, can be brought on by targeted therapy. Additionally, some side effects of other treatment modalities, including radiotherapy, may reduce the rate at which leukemia therapeutic agents are adopted. During the forecast period, these factors are expected to restrain market growth.

Type Outlook

Based on type, the leukemia therapeutics market is segmented into acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and others. In 2022, the chronic lymphocytic leukemia segment held the highest revenue share in the leukemia therapeutics market. Chronic lymphocytic leukemia (CLL) is a cancer that spreads slowly from lymphocytes in the bone marrow to the blood. The three main trends influencing the segment's growth are the accelerated adoption of a less active way of life, an increasing incidence of chronic lymphocytic leukemia, and the growing elderly population.

Distribution Channel Outlook

On the basis of distribution channel, the leukemia therapeutics market is bifurcated into hospital pharmacies, drug store & retail pharmacies and online providers. The online providers segment acquired a substantial revenue share in the leukemia therapeutics market in 2022. This is due to ongoing services and various solutions being readily available. In addition, the market's expansion is also fueled by a surge in e-commerce sales, better logistical services, and simple payment options.

Drug Class Outlook

By drug class, the leukemia therapeutics market is fragmented into chemotherapy, and targeted therapy & immunotherapy. The targeted therapy & immunotherapy segment witnessed the largest revenue share in the leukemia therapeutics market in 2022. Drug therapies that target specific abnormalities in cancer cells are used. Targeted medication therapies can kill cancer cells by obstructing these aberrations. The patient's immune system is used in immunotherapy to combat cancer. Cancer cells create proteins that assist them evade detection by immune system cells, thus the body's immune system that fights disease may not attack the cancer. Immunotherapy works by obstructing that procedure.

Leukemia Therapeutics Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 7.8 Billion
Market size forecast in 2029	USD 11.7 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2029
Revenue Growth Rate	CAGR of 6% from 2023 to 2029
Number of Pages	236
Number of Table	364
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Drug Class, Distribution Channel, Type, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Innovative therapies for leukemia treatments Developing bioinformatics tool to support drug development
Restraints	Side Effects of leukemia therapeutics and strict regulations

Regional Outlook

Region wise, the leukemia therapeutics market is analysed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the leukemia therapeutics market with the maximum revenue share. North America now holds a leading position in the market due to high healthcare spending, many significant players in creating new leukemia medicines, and an increasing number of leukemia patients. Diagnostic clinics, hospitals, and other medical institutions have a lot of medical equipment installed. In the pharmaceutical & biotechnology industries, the United States is home to many original equipment manufacturers that lead the world.

Free Valuable Insights: Global Leukemia Therapeutics Market size to reach USD 11.7 Billion by 2029

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Gilead Sciences, Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Lupin Limited, Amgen, Inc., Takeda Pharmaceutical Company Limited, Pfizer, Inc. and Novartis AG.

Strategies deployed in the Market

» Partnerships, Collaborations and Agreements:

• Dec-2022: Sanofi signed an agreement with Innate Pharma SA, a clinical-stage oncology-focused biotech company, for natural killer cell therapeutics in oncology. Under this agreement, Sanofi would develop, manufacture, and commercialize products resulting from the research collaboration.
• Dec-2022: Gilead collaborated with ImmunoGen, Inc., a pioneer in broadening the field of antibody-drug conjugates (ADCs) for the treatment of cancer. This collaboration aims to evaluate the safety and anti-leukemia activity of pivekimab sunirine in combination with magrolimab, a potential, first-in-class, investigational CD47 inhibitor.
• Oct-2022: Gilead joined hands with MacroGenics, a biopharmaceutical company engaged in the development and commercialization of advanced monoclonal antibody-based therapeutics for the treatment of cancer. Under this collaboration, both companies would develop MGD024, an investigational, bispecific antibody that binds CD3 and CD123 utilizing MacroGenics’ DART® platform.
• Oct-2022: Bristol Myers Squibb signed an agreement with Century Therapeutics, a biotechnology company. This agreement aims to develop and supply up to 4 induced pluripotent stems cell-derived, engineered natural killer cell and T cell programs for hematologic malignancies and solid tumors.
• Mar-2022: Novartis came into an agreement with Carisma Therapeutics, a biopharmaceutical pioneer in macrophage-based therapeutics. Under this agreement, companies would aim to manufacture the HER 2 targeted CAR-M cell therapy, that is tested in initial trials for the treatment of solid tumors.

» Product Launches and Product Expansions:

• Mar-2022: Teva Pharmaceuticals, a U.S.-based affiliate of Teva Pharmaceutical Industries Ltd., introduced Revlimid, the generic version of lenalidomide capsules. This launch offers patients with another key treatment option for highly challenging conditions.

»Approvals & Trials

• Oct-2021: Novartis got FDA approval for Scemblix, a provider of the much-required new option for patients with chronic myeloid leukemia. The Scemblix serves patients who suffer from inadequate or intolerance response after no less than two earlier tyrosine kinase inhibitor (TKI) treatments.
• Sep-2021: Takeda Pharmaceutical Company Limited received FDA approval for EXKIVITY, an Oral Therapy specifically developed for patients with EGFR Exon20 Insertion+ NSCLC. The approval unveiled an effective treatment option for patients with EGFR Exon20 insertion+ NSCLC, fulfilling an urgent requirement for difficult-to-treat cancer.
• Jun-2021: Bristol Myers Squibb received European Commission approval for Onureg, a maintenance therapy in adult patients with acute myeloid leukemia. Onureg is the only, once-daily frontline oral maintenance therapy in the European Union for patients with a wide range of acute myeloid leukemia (AML) subtypes.

» Mergers & Acquisitions:

• Feb-2023: Kite, a Gilead Company, acquired Tmunity Therapeutics, a clinical-stage, biotech company specializing in next-generation CAR T-therapies and technologies. This acquisition aligns with Kite's available in-house cell therapy research capabilities by adding additional licensing agreements, pipeline assets, and platform capabilities.
• Aug-2022: Bristol Myers Squibb acquired Turning Point Therapeutics, Inc., a clinical-stage precision oncology company. Following this acquisition, Bristol Myers Squibb strengthened its oncology franchise through Turning Point's precision oncology franchise.
• Nov-2021: Pfizer, Inc. took over Trillium Therapeutics, a clinical-stage immuno-oncology company engaged in the development of advanced therapies for the treatment of cancer. This acquisition improves Pfizer's Oncology offerings with the addition of next-generation, investigational immuno-therapeutics for haematological malignancies.
• Apr-2021: Sanofi acquired Kiadis, a clinical-stage company developing cell-based immunotherapy products. Following this acquisition, the Kiadis ‘off-the-shelf’ K-NK cell technology platform would have wide applications compared to solid and liquid tumors.

Scope of the Study

Market Segments Covered in the Report:

By Drug Class

• Targeted Therapy & Immunotherapy
• Chemotherapy

By Distribution Channel

• Hospital Pharmacies
• Drug Store & Retail Pharmacies
• Online Providers

By Type

• Chronic Lymphocytic Leukemia
• Acute Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Acute Myeloid Leukemia
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Gilead Sciences, Inc.
• Bristol Myers Squibb Company
• Sanofi S.A.
• AbbVie, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Lupin Limited
• Amgen, Inc.
• Takeda Pharmaceutical Company Limited
• Pfizer, Inc.
• Novartis AG

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Leukemia Therapeutics Market, by Drug Class
1.4.2 Global Leukemia Therapeutics Market, by Distribution Channel
1.4.3 Global Leukemia Therapeutics Market, by Type
1.4.4 Global Leukemia Therapeutics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals & Trails
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, May – 2022, Dec) Leading Players

Chapter 4. Global Leukemia Therapeutics Market by Drug Class
4.1 Global Targeted Therapy & Immunotherapy Market by Region
4.2 Global Chemotherapy Market by Region

Chapter 5. Global Leukemia Therapeutics Market by Distribution Channel
5.1 Global Hospital Pharmacies Market by Region
5.2 Global Drug Store & Retail Pharmacies Market by Region
5.3 Global Online Providers Market by Region

Chapter 6. Global Leukemia Therapeutics Market by Type
6.1 Global Chronic Lymphocytic Leukemia Market by Region
6.2 Global Acute Lymphocytic Leukemia Market by Region
6.3 Global Chronic Myeloid Leukemia Market by Region
6.4 Global Acute Myeloid Leukemia Market by Region
6.5 Global Others Market by Region

Chapter 7. Global Leukemia Therapeutics Market by Region
7.1 North America Leukemia Therapeutics Market
7.1.1 North America Leukemia Therapeutics Market by Drug Class
7.1.1.1 North America Targeted Therapy & Immunotherapy Market by Country
7.1.1.2 North America Chemotherapy Market by Country
7.1.2 North America Leukemia Therapeutics Market by Distribution Channel
7.1.2.1 North America Hospital Pharmacies Market by Country
7.1.2.2 North America Drug Store & Retail Pharmacies Market by Country
7.1.2.3 North America Online Providers Market by Country
7.1.3 North America Leukemia Therapeutics Market by Type
7.1.3.1 North America Chronic Lymphocytic Leukemia Market by Country
7.1.3.2 North America Acute Lymphocytic Leukemia Market by Country
7.1.3.3 North America Chronic Myeloid Leukemia Market by Country
7.1.3.4 North America Acute Myeloid Leukemia Market by Country
7.1.3.5 North America Others Market by Country
7.1.4 North America Leukemia Therapeutics Market by Country
7.1.4.1 US Leukemia Therapeutics Market
7.1.4.1.1 US Leukemia Therapeutics Market by Drug Class
7.1.4.1.2 US Leukemia Therapeutics Market by Distribution Channel
7.1.4.1.3 US Leukemia Therapeutics Market by Type
7.1.4.2 Canada Leukemia Therapeutics Market
7.1.4.2.1 Canada Leukemia Therapeutics Market by Drug Class
7.1.4.2.2 Canada Leukemia Therapeutics Market by Distribution Channel
7.1.4.2.3 Canada Leukemia Therapeutics Market by Type
7.1.4.3 Mexico Leukemia Therapeutics Market
7.1.4.3.1 Mexico Leukemia Therapeutics Market by Drug Class
7.1.4.3.2 Mexico Leukemia Therapeutics Market by Distribution Channel
7.1.4.3.3 Mexico Leukemia Therapeutics Market by Type
7.1.4.4 Rest of North America Leukemia Therapeutics Market
7.1.4.4.1 Rest of North America Leukemia Therapeutics Market by Drug Class
7.1.4.4.2 Rest of North America Leukemia Therapeutics Market by Distribution Channel
7.1.4.4.3 Rest of North America Leukemia Therapeutics Market by Type
7.2 Europe Leukemia Therapeutics Market
7.2.1 Europe Leukemia Therapeutics Market by Drug Class
7.2.1.1 Europe Targeted Therapy & Immunotherapy Market by Country
7.2.1.2 Europe Chemotherapy Market by Country
7.2.2 Europe Leukemia Therapeutics Market by Distribution Channel
7.2.2.1 Europe Hospital Pharmacies Market by Country
7.2.2.2 Europe Drug Store & Retail Pharmacies Market by Country
7.2.2.3 Europe Online Providers Market by Country
7.2.3 Europe Leukemia Therapeutics Market by Type
7.2.3.1 Europe Chronic Lymphocytic Leukemia Market by Country
7.2.3.2 Europe Acute Lymphocytic Leukemia Market by Country
7.2.3.3 Europe Chronic Myeloid Leukemia Market by Country
7.2.3.4 Europe Acute Myeloid Leukemia Market by Country
7.2.3.5 Europe Others Market by Country
7.2.4 Europe Leukemia Therapeutics Market by Country
7.2.4.1 Germany Leukemia Therapeutics Market
7.2.4.1.1 Germany Leukemia Therapeutics Market by Drug Class
7.2.4.1.2 Germany Leukemia Therapeutics Market by Distribution Channel
7.2.4.1.3 Germany Leukemia Therapeutics Market by Type
7.2.4.2 UK Leukemia Therapeutics Market
7.2.4.2.1 UK Leukemia Therapeutics Market by Drug Class
7.2.4.2.2 UK Leukemia Therapeutics Market by Distribution Channel
7.2.4.2.3 UK Leukemia Therapeutics Market by Type
7.2.4.3 France Leukemia Therapeutics Market
7.2.4.3.1 France Leukemia Therapeutics Market by Drug Class
7.2.4.3.2 France Leukemia Therapeutics Market by Distribution Channel
7.2.4.3.3 France Leukemia Therapeutics Market by Type
7.2.4.4 Russia Leukemia Therapeutics Market
7.2.4.4.1 Russia Leukemia Therapeutics Market by Drug Class
7.2.4.4.2 Russia Leukemia Therapeutics Market by Distribution Channel
7.2.4.4.3 Russia Leukemia Therapeutics Market by Type
7.2.4.5 Spain Leukemia Therapeutics Market
7.2.4.5.1 Spain Leukemia Therapeutics Market by Drug Class
7.2.4.5.2 Spain Leukemia Therapeutics Market by Distribution Channel
7.2.4.5.3 Spain Leukemia Therapeutics Market by Type
7.2.4.6 Italy Leukemia Therapeutics Market
7.2.4.6.1 Italy Leukemia Therapeutics Market by Drug Class
7.2.4.6.2 Italy Leukemia Therapeutics Market by Distribution Channel
7.2.4.6.3 Italy Leukemia Therapeutics Market by Type
7.2.4.7 Rest of Europe Leukemia Therapeutics Market
7.2.4.7.1 Rest of Europe Leukemia Therapeutics Market by Drug Class
7.2.4.7.2 Rest of Europe Leukemia Therapeutics Market by Distribution Channel
7.2.4.7.3 Rest of Europe Leukemia Therapeutics Market by Type
7.3 Asia Pacific Leukemia Therapeutics Market
7.3.1 Asia Pacific Leukemia Therapeutics Market by Drug Class
7.3.1.1 Asia Pacific Targeted Therapy & Immunotherapy Market by Country
7.3.1.2 Asia Pacific Chemotherapy Market by Country
7.3.2 Asia Pacific Leukemia Therapeutics Market by Distribution Channel
7.3.2.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.2.2 Asia Pacific Drug Store & Retail Pharmacies Market by Country
7.3.2.3 Asia Pacific Online Providers Market by Country
7.3.3 Asia Pacific Leukemia Therapeutics Market by Type
7.3.3.1 Asia Pacific Chronic Lymphocytic Leukemia Market by Country
7.3.3.2 Asia Pacific Acute Lymphocytic Leukemia Market by Country
7.3.3.3 Asia Pacific Chronic Myeloid Leukemia Market by Country
7.3.3.4 Asia Pacific Acute Myeloid Leukemia Market by Country
7.3.3.5 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Leukemia Therapeutics Market by Country
7.3.4.1 China Leukemia Therapeutics Market
7.3.4.1.1 China Leukemia Therapeutics Market by Drug Class
7.3.4.1.2 China Leukemia Therapeutics Market by Distribution Channel
7.3.4.1.3 China Leukemia Therapeutics Market by Type
7.3.4.2 Japan Leukemia Therapeutics Market
7.3.4.2.1 Japan Leukemia Therapeutics Market by Drug Class
7.3.4.2.2 Japan Leukemia Therapeutics Market by Distribution Channel
7.3.4.2.3 Japan Leukemia Therapeutics Market by Type
7.3.4.3 India Leukemia Therapeutics Market
7.3.4.3.1 India Leukemia Therapeutics Market by Drug Class
7.3.4.3.2 India Leukemia Therapeutics Market by Distribution Channel
7.3.4.3.3 India Leukemia Therapeutics Market by Type
7.3.4.4 South Korea Leukemia Therapeutics Market
7.3.4.4.1 South Korea Leukemia Therapeutics Market by Drug Class
7.3.4.4.2 South Korea Leukemia Therapeutics Market by Distribution Channel
7.3.4.4.3 South Korea Leukemia Therapeutics Market by Type
7.3.4.5 Singapore Leukemia Therapeutics Market
7.3.4.5.1 Singapore Leukemia Therapeutics Market by Drug Class
7.3.4.5.2 Singapore Leukemia Therapeutics Market by Distribution Channel
7.3.4.5.3 Singapore Leukemia Therapeutics Market by Type
7.3.4.6 Malaysia Leukemia Therapeutics Market
7.3.4.6.1 Malaysia Leukemia Therapeutics Market by Drug Class
7.3.4.6.2 Malaysia Leukemia Therapeutics Market by Distribution Channel
7.3.4.6.3 Malaysia Leukemia Therapeutics Market by Type
7.3.4.7 Rest of Asia Pacific Leukemia Therapeutics Market
7.3.4.7.1 Rest of Asia Pacific Leukemia Therapeutics Market by Drug Class
7.3.4.7.2 Rest of Asia Pacific Leukemia Therapeutics Market by Distribution Channel
7.3.4.7.3 Rest of Asia Pacific Leukemia Therapeutics Market by Type
7.4 LAMEA Leukemia Therapeutics Market
7.4.1 LAMEA Leukemia Therapeutics Market by Drug Class
7.4.1.1 LAMEA Targeted Therapy & Immunotherapy Market by Country
7.4.1.2 LAMEA Chemotherapy Market by Country
7.4.2 LAMEA Leukemia Therapeutics Market by Distribution Channel
7.4.2.1 LAMEA Hospital Pharmacies Market by Country
7.4.2.2 LAMEA Drug Store & Retail Pharmacies Market by Country
7.4.2.3 LAMEA Online Providers Market by Country
7.4.3 LAMEA Leukemia Therapeutics Market by Type
7.4.3.1 LAMEA Chronic Lymphocytic Leukemia Market by Country
7.4.3.2 LAMEA Acute Lymphocytic Leukemia Market by Country
7.4.3.3 LAMEA Chronic Myeloid Leukemia Market by Country
7.4.3.4 LAMEA Acute Myeloid Leukemia Market by Country
7.4.3.5 LAMEA Others Market by Country
7.4.4 LAMEA Leukemia Therapeutics Market by Country
7.4.4.1 Brazil Leukemia Therapeutics Market
7.4.4.1.1 Brazil Leukemia Therapeutics Market by Drug Class
7.4.4.1.2 Brazil Leukemia Therapeutics Market by Distribution Channel
7.4.4.1.3 Brazil Leukemia Therapeutics Market by Type
7.4.4.2 Argentina Leukemia Therapeutics Market
7.4.4.2.1 Argentina Leukemia Therapeutics Market by Drug Class
7.4.4.2.2 Argentina Leukemia Therapeutics Market by Distribution Channel
7.4.4.2.3 Argentina Leukemia Therapeutics Market by Type
7.4.4.3 UAE Leukemia Therapeutics Market
7.4.4.3.1 UAE Leukemia Therapeutics Market by Drug Class
7.4.4.3.2 UAE Leukemia Therapeutics Market by Distribution Channel
7.4.4.3.3 UAE Leukemia Therapeutics Market by Type
7.4.4.4 Saudi Arabia Leukemia Therapeutics Market
7.4.4.4.1 Saudi Arabia Leukemia Therapeutics Market by Drug Class
7.4.4.4.2 Saudi Arabia Leukemia Therapeutics Market by Distribution Channel
7.4.4.4.3 Saudi Arabia Leukemia Therapeutics Market by Type
7.4.4.5 South Africa Leukemia Therapeutics Market
7.4.4.5.1 South Africa Leukemia Therapeutics Market by Drug Class
7.4.4.5.2 South Africa Leukemia Therapeutics Market by Distribution Channel
7.4.4.5.3 South Africa Leukemia Therapeutics Market by Type
7.4.4.6 Nigeria Leukemia Therapeutics Market
7.4.4.6.1 Nigeria Leukemia Therapeutics Market by Drug Class
7.4.4.6.2 Nigeria Leukemia Therapeutics Market by Distribution Channel
7.4.4.6.3 Nigeria Leukemia Therapeutics Market by Type
7.4.4.7 Rest of LAMEA Leukemia Therapeutics Market
7.4.4.7.1 Rest of LAMEA Leukemia Therapeutics Market by Drug Class
7.4.4.7.2 Rest of LAMEA Leukemia Therapeutics Market by Distribution Channel
7.4.4.7.3 Rest of LAMEA Leukemia Therapeutics Market by Type

Chapter 8. Company Profiles
8.1 Gilead Sciences, Inc.
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Acquisition and Mergers:
8.2 Bristol Myers Squibb Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.5.2 Partnerships, Collaborations and Agreements:
8.2.5.3 Approvals and Trials:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Trials and Approvals:
8.3.5.3 Acquisitions and Mergers:
8.4 AbbVie, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Approvals & Trials:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Lupin Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Product Launches and Product Expansions:
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Trials and Approvals:
8.8 Takeda Pharmaceutical Company Limited
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Approvals & Trials:
8.9 Pfizer, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional & Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Approvals & Trials:
8.9.5.2 Acquisition and Mergers:
8.10. Novartis AG
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expense
8.10.4 Recent strategies and developments:
8.10.4.1 Partnerships, Collaborations, and Agreements:
8.10.4.2 Approvals & Trials:

TABLE 1 Global Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Global Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Leukemia Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Leukemia Therapeutics Market
TABLE 5 Acquisition and Mergers– Leukemia Therapeutics Market
TABLE 6 Approvals & Trials– Leukemia Therapeutics Market
TABLE 7 Global Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 8 Global Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 9 Global Targeted Therapy & Immunotherapy Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Targeted Therapy & Immunotherapy Market by Region, 2023 - 2029, USD Million
TABLE 11 Global Chemotherapy Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Chemotherapy Market by Region, 2023 - 2029, USD Million
TABLE 13 Global Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 14 Global Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 15 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 17 Global Drug Store & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Drug Store & Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 19 Global Online Providers Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Online Providers Market by Region, 2023 - 2029, USD Million
TABLE 21 Global Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 22 Global Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 23 Global Chronic Lymphocytic Leukemia Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Chronic Lymphocytic Leukemia Market by Region, 2023 - 2029, USD Million
TABLE 25 Global Acute Lymphocytic Leukemia Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Acute Lymphocytic Leukemia Market by Region, 2023 - 2029, USD Million
TABLE 27 Global Chronic Myeloid Leukemia Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Chronic Myeloid Leukemia Market by Region, 2023 - 2029, USD Million
TABLE 29 Global Acute Myeloid Leukemia Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Acute Myeloid Leukemia Market by Region, 2023 - 2029, USD Million
TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 32 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 33 Global Leukemia Therapeutics Market by Region, 2019 - 2022, USD Million
TABLE 34 Global Leukemia Therapeutics Market by Region, 2023 - 2029, USD Million
TABLE 35 North America Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 36 North America Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 37 North America Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 North America Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 39 North America Targeted Therapy & Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Targeted Therapy & Immunotherapy Market by Country, 2023 - 2029, USD Million
TABLE 41 North America Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 43 North America Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 North America Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 45 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 47 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 49 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 51 North America Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 52 North America Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 53 North America Chronic Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Chronic Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 55 North America Acute Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Acute Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 57 North America Chronic Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Chronic Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 59 North America Acute Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Acute Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 61 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 62 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 63 North America Leukemia Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 64 North America Leukemia Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 65 US Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 66 US Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 67 US Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 68 US Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 69 US Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 US Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 US Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 72 US Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 73 Canada Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 74 Canada Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 75 Canada Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 76 Canada Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 77 Canada Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 78 Canada Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 79 Canada Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 80 Canada Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 81 Mexico Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 82 Mexico Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 83 Mexico Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 84 Mexico Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 85 Mexico Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Mexico Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 87 Mexico Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 88 Mexico Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 89 Rest of North America Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 90 Rest of North America Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 91 Rest of North America Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 92 Rest of North America Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 93 Rest of North America Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 94 Rest of North America Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 95 Rest of North America Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 96 Rest of North America Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 97 Europe Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 98 Europe Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 99 Europe Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 100 Europe Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 101 Europe Targeted Therapy & Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 102 Europe Targeted Therapy & Immunotherapy Market by Country, 2023 - 2029, USD Million
TABLE 103 Europe Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 104 Europe Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 105 Europe Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 106 Europe Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 107 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 109 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 110 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 111 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 112 Europe Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 113 Europe Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 114 Europe Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 115 Europe Chronic Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Chronic Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 117 Europe Acute Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Acute Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 119 Europe Chronic Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Chronic Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 121 Europe Acute Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 122 Europe Acute Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 125 Europe Leukemia Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 126 Europe Leukemia Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 127 Germany Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 128 Germany Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 129 Germany Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 130 Germany Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 131 Germany Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 132 Germany Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 133 Germany Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 134 Germany Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 135 UK Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 136 UK Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 137 UK Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 138 UK Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 139 UK Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 UK Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 141 UK Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 142 UK Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 143 France Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 144 France Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 145 France Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 146 France Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 147 France Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 148 France Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 149 France Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 150 France Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 151 Russia Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 152 Russia Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 153 Russia Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 154 Russia Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 155 Russia Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 156 Russia Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 157 Russia Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 158 Russia Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 159 Spain Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 160 Spain Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 161 Spain Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 162 Spain Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 163 Spain Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 164 Spain Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 165 Spain Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 166 Spain Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 167 Italy Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 168 Italy Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 169 Italy Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 170 Italy Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 171 Italy Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 172 Italy Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 173 Italy Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 174 Italy Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 175 Rest of Europe Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 176 Rest of Europe Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 177 Rest of Europe Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 178 Rest of Europe Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 179 Rest of Europe Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 180 Rest of Europe Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 181 Rest of Europe Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 182 Rest of Europe Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 183 Asia Pacific Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 184 Asia Pacific Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 185 Asia Pacific Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 186 Asia Pacific Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 187 Asia Pacific Targeted Therapy & Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 188 Asia Pacific Targeted Therapy & Immunotherapy Market by Country, 2023 - 2029, USD Million
TABLE 189 Asia Pacific Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 190 Asia Pacific Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 191 Asia Pacific Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 192 Asia Pacific Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 193 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 194 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 195 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 196 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 197 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 198 Asia Pacific Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 199 Asia Pacific Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 200 Asia Pacific Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 201 Asia Pacific Chronic Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Chronic Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 203 Asia Pacific Acute Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Acute Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 205 Asia Pacific Chronic Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Chronic Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 207 Asia Pacific Acute Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Acute Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 209 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 211 Asia Pacific Leukemia Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Leukemia Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 213 China Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 214 China Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 215 China Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 216 China Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 217 China Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 218 China Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 219 China Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 220 China Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 221 Japan Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 222 Japan Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 223 Japan Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 224 Japan Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 225 Japan Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 226 Japan Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 227 Japan Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 228 Japan Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 229 India Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 230 India Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 231 India Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 232 India Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 233 India Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 234 India Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 235 India Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 236 India Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 237 South Korea Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 238 South Korea Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 239 South Korea Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 240 South Korea Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 241 South Korea Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 242 South Korea Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 243 South Korea Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 244 South Korea Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 245 Singapore Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 246 Singapore Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 247 Singapore Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 248 Singapore Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 249 Singapore Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 250 Singapore Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 251 Singapore Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 252 Singapore Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 253 Malaysia Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 254 Malaysia Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 255 Malaysia Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 256 Malaysia Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 257 Malaysia Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 258 Malaysia Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 259 Malaysia Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 260 Malaysia Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 261 Rest of Asia Pacific Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 262 Rest of Asia Pacific Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 263 Rest of Asia Pacific Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 264 Rest of Asia Pacific Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 265 Rest of Asia Pacific Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 266 Rest of Asia Pacific Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 267 Rest of Asia Pacific Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 268 Rest of Asia Pacific Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 269 LAMEA Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 270 LAMEA Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 271 LAMEA Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 272 LAMEA Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 273 LAMEA Targeted Therapy & Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 274 LAMEA Targeted Therapy & Immunotherapy Market by Country, 2023 - 2029, USD Million
TABLE 275 LAMEA Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 276 LAMEA Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 277 LAMEA Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 278 LAMEA Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 279 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 280 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 281 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 282 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 283 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 284 LAMEA Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 285 LAMEA Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 286 LAMEA Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 287 LAMEA Chronic Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 288 LAMEA Chronic Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 289 LAMEA Acute Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 290 LAMEA Acute Lymphocytic Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 291 LAMEA Chronic Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 292 LAMEA Chronic Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 293 LAMEA Acute Myeloid Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 294 LAMEA Acute Myeloid Leukemia Market by Country, 2023 - 2029, USD Million
TABLE 295 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 296 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 297 LAMEA Leukemia Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 298 LAMEA Leukemia Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 299 Brazil Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 300 Brazil Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 301 Brazil Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 302 Brazil Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 303 Brazil Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 304 Brazil Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 305 Brazil Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 306 Brazil Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 307 Argentina Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 308 Argentina Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 309 Argentina Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 310 Argentina Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 311 Argentina Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 312 Argentina Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 313 Argentina Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 314 Argentina Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 315 UAE Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 316 UAE Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 317 UAE Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 318 UAE Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 319 UAE Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 320 UAE Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 321 UAE Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 322 UAE Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 323 Saudi Arabia Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 324 Saudi Arabia Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 325 Saudi Arabia Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 326 Saudi Arabia Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 327 Saudi Arabia Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 328 Saudi Arabia Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 329 Saudi Arabia Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 330 Saudi Arabia Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 331 South Africa Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 332 South Africa Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 333 South Africa Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 334 South Africa Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 335 South Africa Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 336 South Africa Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 337 South Africa Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 338 South Africa Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 339 Nigeria Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 340 Nigeria Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 341 Nigeria Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 342 Nigeria Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 343 Nigeria Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 344 Nigeria Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 345 Nigeria Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 346 Nigeria Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 347 Rest of LAMEA Leukemia Therapeutics Market, 2019 - 2022, USD Million
TABLE 348 Rest of LAMEA Leukemia Therapeutics Market, 2023 - 2029, USD Million
TABLE 349 Rest of LAMEA Leukemia Therapeutics Market by Drug Class, 2019 - 2022, USD Million
TABLE 350 Rest of LAMEA Leukemia Therapeutics Market by Drug Class, 2023 - 2029, USD Million
TABLE 351 Rest of LAMEA Leukemia Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 352 Rest of LAMEA Leukemia Therapeutics Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 353 Rest of LAMEA Leukemia Therapeutics Market by Type, 2019 - 2022, USD Million
TABLE 354 Rest of LAMEA Leukemia Therapeutics Market by Type, 2023 - 2029, USD Million
TABLE 355 Key Information – Gilead Sciences, Inc.
TABLE 356 Key Information – Bristol Myers Squibb Company
TABLE 357 Key Information – Sanofi S.A.
TABLE 358 Key information – AbbVie, Inc.
TABLE 359 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 360 Key Information – Lupin Limited
TABLE 361 Key Information – Amgen, Inc.
TABLE 362 Key Information – Takeda Pharmaceutical Company Limited
TABLE 363 Key Information – Pfizer, Inc.
TABLE 364 Key Information – Novartis AG

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, May – 2022, Dec) Leading Players
FIG 5 Global Leukemia Therapeutics Market Share by Drug Class, 2022
FIG 6 Global Leukemia Therapeutics Market Share by Drug Class, 2029
FIG 7 Global Leukemia Therapeutics Market by Drug Class, 2019 - 2029, USD Million
FIG 8 Global Leukemia Therapeutics Market Share by Distribution Channel, 2022
FIG 9 Global Leukemia Therapeutics Market Share by Distribution Channel, 2029
FIG 10 Global Leukemia Therapeutics Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 Global Leukemia Therapeutics Market Share by Type, 2022
FIG 12 Global Leukemia Therapeutics Market Share by Type, 2029
FIG 13 Global Leukemia Therapeutics Market by Type, 2019 - 2029, USD Million
FIG 14 Global Leukemia Therapeutics Market Share by Region, 2022
FIG 15 Global Leukemia Therapeutics Market Share by Region, 2029
FIG 16 Global Leukemia Therapeutics Market by Region, 2019 - 2029, USD Million
FIG 17 Recent strategies and developments: Gilead Sciences, Inc.
FIG 18 Recent strategies and developments: Bristol Myers Squibb Company
FIG 19 Recent strategies and developments: Sanofi S.A.